04:56 PM EST, 03/07/2024 (MT Newswires) -- Paul A Mahon, Executive Vice President & General Counsel, on March 07, 2024, sold 6,000 shares in United Therapeutics ( UTHR ) for $1,424,309. Following the Form 4 filing with the SEC, Mahon has control over a total of 36,599 shares of the company, with 36,599 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000141588924007191/xslF345X03/form4-03072024_090331.xml

Price: 239.77, Change: -0.19, Percent Change: -0.08